Log In
Print
BCIQ
Print
Print this Print this
 

VSN16R

  Manage Alerts
Collapse Summary General Information
Company Canbex Therapeutics Ltd.
DescriptionAnti-spastic oral small molecule
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationSpasticity
Indication DetailsTreat spasticity in multiple sclerosis (MS) patients
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today